UPDATE : Monday, October 21, 2019
Loss-making Medipost seeks to avoid administrative issue designation by Jeong Sae-im 2019-03-14 14:33
Celltrion Healthcare wins biosimilar bids in SE Asia by Lee Han-soo 2019-03-07 14:25
Biogen seeks gene therapy pipeline for rare eye disease by Kim Yun-mi 2019-03-06 14:41
Europe OKs Samsung Bioepis’ biosimilar treatment of breast cancer by Lee Han-soo 2019-03-05 17:53
Bridge Biotherapeutics to accelerate global presence by Lee Han-soo 2019-03-04 10:50
BioGenetics inks deal to supply biliary tract cancer drug in Korea by Lee Hye-seon 2019-02-28 16:49
Researchers find biomarker to predict recurrence of chronic myeloid leukemia by Park Gi-taek 2019-02-25 16:03
Celltrion Healthcare posts ₩713.5 billion in 2018 sales by Lee Han-soo 2019-02-22 17:29
Alteogen applies for P1 trial for Eylea biosimilar by Lee Han-soo 2019-02-22 16:03
Samsung Bioepis, C-Bridge Capital to develop biosimilars in China by Lee Han-soo 2019-02-11 11:23
Samsung BioLogics posts ₩535.8 billion in 2018 sales by Lee Han-soo 2019-02-01 11:56
Celltrion to export biosimilars to Latin America by Lee Han-soo 2019-01-31 11:12
Samsung Bioepis’ biosimilar sales in EU exceed $500 million by Lee Han-soo 2019-01-30 18:17
KIST finds boiling histotripsy’s mechanism to remove tumor tissue by Cho In-sung 2019-01-24 11:30
FDA OKs Samsung Bioepis’ first oncology medicine by Lee Han-soo 2019-01-21 11:43
Celltrion wins patent dispute on Truxima by Lee Han-soo 2019-01-18 11:47
Over 1,000 bio-ventures set up in past 3 years by Lee Han-soo 2019-01-17 22:05
CL Bio wins patent for substance that improves antidiabetic functions by Lee Han-soo 2019-01-14 12:34
Medipost, LG Chem to develop stem cell therapy by Lee Han-soo 2019-01-08 17:55
Samsung Bioepis to expand business in China by Lee Han-soo 2019-01-07 12:30
Back to Top